Market Overview:
The global drug-eluting stents market reached a value of US$ XX Billion in 2021. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
A drug-eluting stent (DES) is a coronary device that is used for the slow release of drugs in peripheral or coronary arteries to block cell proliferation and promote a healthy flow of blood. It consists of a metallic stent, polymer coating and anti-restenosis drug. The stent is coated with medications that assist the arteries to remain smooth and ensure adequate blood flow. DES is widely used to treat blockages in heart arteries, prevent plaque buildup, blood clots and reduce repeated revascularization. The stent is minimally invasive (MI) and offers lower restenosis rates, enhanced vessel healing and reduced need for prolonged dual antiplatelet therapy.
Drug-Eluting Stents Market Trends:
The rising geriatric population prone to chronic medical ailments is one of the key factors driving the growth of the market. DES is widely utilized in patients with a high risk of developing arterial disorders as the stents aid in reducing the need for invasive procedures, such as coronary artery bypass surgeries. Additionally, the increasing prevalence of cardiovascular diseases due to the unhealthy dietary patterns, lack of physical activity and sedentary lifestyles of the masses is favoring the market growth. Moreover, various technological advancements, such as the launch of bioresorbable stents, are providing a thrust to the market growth. These stents are easily dissolvable in the body and reduce the risk of developing stent thrombosis. In line with this, the widespread adoption of stents with polymer-free coatings is positively impacting the market growth. These stents exhibit a higher drug loading capacity and quicker drug-eluting rate. Other factors, including the rising incidence of abnormal heart rhythms, heart failure and heart attack disease, along with the increasing demand for MI techniques among the masses, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global drug-eluting stents market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on coating, drug, stent platform, generation, application and end user.
Breakup by Coating:
- Polymer Based Coating
- Polymer Free Coating
Breakup by Drug:
- Sirolimus
- Paclitaxel
- Zotarolimus
- Everolimus
- Biolimus
- Others
Breakup by Stent Platform:
- Stainless-steel
- Cobalt-Chromium
- Platinum-Chromium
- Nitinol
- Others
Breakup by Generation:
- 1st Generation
- 2nd Generation
- 3rd Generation
- 4th Generation
Breakup by Application:
- Coronary Artery Disease
- Peripheral Artery Disease
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, Biosensors International Group Ltd., Biotronik, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC (Cook Group Incorporated), Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, MicroPort Scientific Corporation, Sino Medical Sciences Technology Inc. and Terumo Corporation.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Coating, Drug, Stent Platform, Generation, Application, End User, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Abbott Laboratories, B. Braun Melsungen AG, Biosensors International Group Ltd., Biotronik, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC (Cook Group Incorporated), Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, MicroPort Scientific Corporation, Sino Medical Sciences Technology Inc. and Terumo Corporation. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global drug-eluting stents market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global drug-eluting stents market?
- What are the key regional markets?
- What is the breakup of the market based on the coating?
- What is the breakup of the market based on the drug?
- What is the breakup of the market based on the stent platform?
- What is the breakup of the market based on the generation?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global drug-eluting stents market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Drug-Eluting Stents Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Coating
6.1 Polymer Based Coating
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Polymer Free Coating
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Drug
7.1 Sirolimus
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Paclitaxel
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Zotarolimus
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Everolimus
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Biolimus
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Stent Platform
8.1 Stainless-steel
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Cobalt-Chromium
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Platinum-Chromium
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Nitinol
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Generation
9.1 1st Generation
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 2nd Generation
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 3rd Generation
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 4th Generation
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Application
10.1 Coronary Artery Disease
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Peripheral Artery Disease
10.2.1 Market Trends
10.2.2 Market Forecast
11 Market Breakup by End User
11.1 Hospitals
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Ambulatory Surgical Centers
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Others
11.3.1 Market Trends
11.3.2 Market Forecast
12 Market Breakup by Region
12.1 North America
12.1.1 United States
12.1.1.1 Market Trends
12.1.1.2 Market Forecast
12.1.2 Canada
12.1.2.1 Market Trends
12.1.2.2 Market Forecast
12.2 Asia-Pacific
12.2.1 China
12.2.1.1 Market Trends
12.2.1.2 Market Forecast
12.2.2 Japan
12.2.2.1 Market Trends
12.2.2.2 Market Forecast
12.2.3 India
12.2.3.1 Market Trends
12.2.3.2 Market Forecast
12.2.4 South Korea
12.2.4.1 Market Trends
12.2.4.2 Market Forecast
12.2.5 Australia
12.2.5.1 Market Trends
12.2.5.2 Market Forecast
12.2.6 Indonesia
12.2.6.1 Market Trends
12.2.6.2 Market Forecast
12.2.7 Others
12.2.7.1 Market Trends
12.2.7.2 Market Forecast
12.3 Europe
12.3.1 Germany
12.3.1.1 Market Trends
12.3.1.2 Market Forecast
12.3.2 France
12.3.2.1 Market Trends
12.3.2.2 Market Forecast
12.3.3 United Kingdom
12.3.3.1 Market Trends
12.3.3.2 Market Forecast
12.3.4 Italy
12.3.4.1 Market Trends
12.3.4.2 Market Forecast
12.3.5 Spain
12.3.5.1 Market Trends
12.3.5.2 Market Forecast
12.3.6 Russia
12.3.6.1 Market Trends
12.3.6.2 Market Forecast
12.3.7 Others
12.3.7.1 Market Trends
12.3.7.2 Market Forecast
12.4 Latin America
12.4.1 Brazil
12.4.1.1 Market Trends
12.4.1.2 Market Forecast
12.4.2 Mexico
12.4.2.1 Market Trends
12.4.2.2 Market Forecast
12.4.3 Others
12.4.3.1 Market Trends
12.4.3.2 Market Forecast
12.5 Middle East and Africa
12.5.1 Market Trends
12.5.2 Market Breakup by Country
12.5.3 Market Forecast
13 SWOT Analysis
13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats
14 Value Chain Analysis
15 Porters Five Forces Analysis
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes
16 Price Analysis
17 Competitive Landscape
17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players
17.3.1 Abbott Laboratories
17.3.1.1 Company Overview
17.3.1.2 Product Portfolio
17.3.1.3 Financials
17.3.1.4 SWOT Analysis
17.3.2 B. Braun Melsungen AG
17.3.2.1 Company Overview
17.3.2.2 Product Portfolio
17.3.2.3 SWOT Analysis
17.3.3 Biosensors International Group Ltd.
17.3.3.1 Company Overview
17.3.3.2 Product Portfolio
17.3.4 Biotronik
17.3.4.1 Company Overview
17.3.4.2 Product Portfolio
17.3.4.3 SWOT Analysis
17.3.5 Boston Scientific Corporation
17.3.5.1 Company Overview
17.3.5.2 Product Portfolio
17.3.5.3 Financials
17.3.5.4 SWOT Analysis
17.3.6 Cardinal Health Inc.
17.3.6.1 Company Overview
17.3.6.2 Product Portfolio
17.3.6.3 Financials
17.3.6.4 SWOT Analysis
17.3.7 Cook Medical LLC (Cook Group Incorporated)
17.3.7.1 Company Overview
17.3.7.2 Product Portfolio
17.3.7.3 SWOT Analysis
17.3.8 Lepu Medical Technology (Beijing) Co. Ltd.
17.3.8.1 Company Overview
17.3.8.2 Product Portfolio
17.3.8.3 Financials
17.3.9 Medtronic plc
17.3.9.1 Company Overview
17.3.9.2 Product Portfolio
17.3.9.3 Financials
17.3.9.4 SWOT Analysis
17.3.10 MicroPort Scientific Corporation
17.3.10.1 Company Overview
17.3.10.2 Product Portfolio
17.3.11 Sino Medical Sciences Technology Inc.
17.3.11.1 Company Overview
17.3.11.2 Product Portfolio
17.3.12 Terumo Corporation
17.3.12.1 Company Overview
17.3.12.2 Product Portfolio
17.3.12.3 Financials
17.3.12.4 SWOT Analysis
List of Figures
Figure 1: Global: Drug-Eluting Stents Market: Major Drivers and Challenges
Figure 2: Global: Drug-Eluting Stents Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Drug-Eluting Stents Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Drug-Eluting Stents Market: Breakup by Coating (in %), 2021
Figure 5: Global: Drug-Eluting Stents Market: Breakup by Drug (in %), 2021
Figure 6: Global: Drug-Eluting Stents Market: Breakup by Stent Platform (in %), 2021
Figure 7: Global: Drug-Eluting Stents Market: Breakup by Generation (in %), 2021
Figure 8: Global: Drug-Eluting Stents Market: Breakup by Application (in %), 2021
Figure 9: Global: Drug-Eluting Stents Market: Breakup by End User (in %), 2021
Figure 10: Global: Drug-Eluting Stents Market: Breakup by Region (in %), 2021
Figure 11: Global: Drug-Eluting Stents (Polymer Based Coating) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Drug-Eluting Stents (Polymer Based Coating) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Drug-Eluting Stents (Polymer Free Coating) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Drug-Eluting Stents (Polymer Free Coating) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Drug-Eluting Stents (Sirolimus) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Drug-Eluting Stents (Sirolimus) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Drug-Eluting Stents (Paclitaxel) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Drug-Eluting Stents (Paclitaxel) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Drug-Eluting Stents (Zotarolimus) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Drug-Eluting Stents (Zotarolimus) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Drug-Eluting Stents (Everolimus) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Drug-Eluting Stents (Everolimus) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Drug-Eluting Stents (Biolimus) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Drug-Eluting Stents (Biolimus) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Drug-Eluting Stents (Other Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Drug-Eluting Stents (Other Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Drug-Eluting Stents (Stainless-steel) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Drug-Eluting Stents (Stainless-steel) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Drug-Eluting Stents (Cobalt-Chromium) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Drug-Eluting Stents (Cobalt-Chromium) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Drug-Eluting Stents (Platinum-Chromium) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Drug-Eluting Stents (Platinum-Chromium) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Drug-Eluting Stents (Nitinol) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Drug-Eluting Stents (Nitinol) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Drug-Eluting Stents (Other Stent Platforms) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Drug-Eluting Stents (Other Stent Platforms) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Drug-Eluting Stents (1st Generation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Drug-Eluting Stents (1st Generation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Drug-Eluting Stents (2nd Generation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Drug-Eluting Stents (2nd Generation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Global: Drug-Eluting Stents (3rd Generation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Drug-Eluting Stents (3rd Generation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Global: Drug-Eluting Stents (4th Generation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Global: Drug-Eluting Stents (4th Generation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Global: Drug-Eluting Stents (Coronary Artery Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Global: Drug-Eluting Stents (Coronary Artery Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Global: Drug-Eluting Stents (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Global: Drug-Eluting Stents (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Global: Drug-Eluting Stents (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Global: Drug-Eluting Stents (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: North America: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: North America: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: United States: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: United States: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Canada: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Canada: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Asia-Pacific: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Asia-Pacific: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: China: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: China: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Japan: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Japan: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: India: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: India: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: South Korea: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: South Korea: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Australia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Australia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Indonesia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Indonesia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Europe: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Europe: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Germany: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Germany: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: France: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: France: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: United Kingdom: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: United Kingdom: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Italy: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Italy: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Spain: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Spain: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Russia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 90: Russia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 91: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 92: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 93: Latin America: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 94: Latin America: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 95: Brazil: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 96: Brazil: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 97: Mexico: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 98: Mexico: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 99: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 100: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 101: Middle East and Africa: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 102: Middle East and Africa: Drug-Eluting Stents Market: Breakup by Country (in %), 2021
Figure 103: Middle East and Africa: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 104: Global: Drug-Eluting Stents Industry: SWOT Analysis
Figure 105: Global: Drug-Eluting Stents Industry: Value Chain Analysis
Figure 106: Global: Drug-Eluting Stents Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Drug-Eluting Stents Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Drug-Eluting Stents Market Forecast: Breakup by Coating (in Million US$), 2022-2027
Table 3: Global: Drug-Eluting Stents Market Forecast: Breakup by Drug (in Million US$), 2022-2027
Table 4: Global: Drug-Eluting Stents Market Forecast: Breakup by Stent Platform (in Million US$), 2022-2027
Table 5: Global: Drug-Eluting Stents Market Forecast: Breakup by Generation (in Million US$), 2022-2027
Table 6: Global: Drug-Eluting Stents Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 7: Global: Drug-Eluting Stents Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 8: Global: Drug-Eluting Stents Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 9: Global: Drug-Eluting Stents Market: Competitive Structure
Table 10: Global: Drug-Eluting Stents Market: Key Players